Universal Ibogaine Inc. (TSXV:IBO)
Canada · Delayed Price · Currency is CAD 0.0050
-0.0050 (-50.00%)
At close: Feb 2, 2026
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of CAD 1.56 million as of February 10, 2026. Its market cap has decreased by -49.31% in one year.
Market Cap
1.56M
Enterprise Value
4.01M
Revenue
2.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 34.23M to 1.56M, a decrease of -95.43%. That is a compound annual growth rate of -50.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 1.56M | - |
| Dec 31, 2025 | 1.56M | 1.38% |
| Dec 31, 2024 | 1.54M | 60.91% |
| Dec 28, 2023 | 958.97K | -66.61% |
| Dec 30, 2022 | 2.87M | -87.94% |
| Dec 31, 2021 | 23.82M | -30.41% |
| Oct 5, 2021 | 34.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gemina Laboratories | 4.59M |
| XORTX Therapeutics | 4.04M |
| MindBio Therapeutics | 3.84M |
| Appili Therapeutics | 3.21M |
| Rakovina Therapeutics | 3.07M |
| ASEP Medical Holdings | 3.00M |
| Algernon Health | 2.36M |
| Nirvana Life Sciences | 1.60M |